Avid Bioservices (NASDAQ: CDMO) is a specialised contract development and manufacturing organisation (CDMO) with a strong focus on the development and CGMP manufacturing of biologics. The company leverages over 30 years of experience in providing a comprehensive array of process development and CGMP clinical and commercial manufacturing services tailored for the biotechnology and biopharmaceutical industries. Avid’s offerings encompass drug substance manufacturing, bulk packaging, release and stability testing, as well as support for regulatory submissions. Their extensive capabilities also include a suite of services dedicated to early-stage programmes, such as cell line development, process optimisation, and analytical methods development, which are essential in advancing therapeutics to commercialisation.

Services include:
- Biologics
- Cell and Gene Therapy
- Drug Substance Manufacturing (API)
- Research & Development
- Analytical Methods Development
- Regulatory Services
- Protein and Peptide
- Analytical Services
- Accelerated Stability Studies
- Assay Development
- Bioanalytical Services
- Biological Testing
- Process Development
- Bioprocess Validation
- Bioprocessing
- Disposable/Single-Use
- Biosimilars
- Chromatography
- Clean in Place / Sterilization in Place (CIP/SIP)
- Chemistry (CMC)
- Manufacturing
- Contract Development and Manufacturing (CDMO)
- Contract Manufacturing (CMO)
- Downstream Processing
- Drug Development
- Feasibility Studies
- Forced Degradation Studies
- Gene Therapy & Testing Protocols
- High Throughput Screening
- Lot Release Testing
- Mammalian Cell Culture
- Antibody-Drug Conjugates
- APIs (Active Pharmaceutical Ingredients)
- Clinical Trial Materials
- Proteins
- Vaccines
- Process Characterization
- Process R&D
- Process Validation Studies
- Project Management
- Protein Extraction/Purification
- Purification
- Quality QA/QC
- R&D Services
- Scale-Up
- Stability Studies
- Stability
- ICH
- Technology Transfer
- Validation

Avid Bioservices continues to strengthen its position in the pharmaceutical industry by providing innovative solutions and comprehensive support throughout the drug development process. For more information, please visit avidbio.com.